On May 29th, according to a report from NZ Herald, a recent opinion poll showed that over two-thirds of New Zealanders are in favor of following Australia's lead in allowing electronic cigarettes to be purchased only with a prescription. Child health experts have voiced their support for this measure.
According to the report, a public opinion survey called Newshub Reid Research asked the question, "Should we ban recreational electronic cigarettes?" The survey results showed that 68% of respondents were in favor of the ban, while 27% held a different opinion.
However, New Zealand's Minister of Health, Ayesha Verrall, previously stated that the government is not currently actively considering following Australia's lead in banning all e-cigarette products for recreational use. Verrall emphasized that these products need to remain "readily available" as tobacco regulations are strengthened.
It has been reported that New Zealand is planning to become a "smoke-free country" by 2025 and is promoting the use of electronic cigarettes to help smokers quit smoking.
Reference:
A recent poll regarding vaping has found that over 66% of individuals in New Zealand are in favour of a ban on vaping.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
